Intestinal Bacteria Flora Disturbance
16
0
1
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (16)
Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study
Use Babyguard® Breast Milk Probiotics to Verify the Authenticity of the Gut-Breast Axis Hypothesis
Fucoidan Assisted Eradication of Helicobacter Pylori
Allium Extracts on the Intestinal Microbiota in Healthy Resident Volunteers.
The Effect of Probiotics on Gut Microbiotain After Helicobacter Pylori Eradication
Fecal Microbiota Transplantation for Pancreatitis
The Effect of Fruit/Vegetable Drinks on the Human Intestine
Evaluation of the Effect of Palm Olein Free Formula on Intestinal Flora and Gastrointestinal Tolerance
Study on Dietary Nutrition Intervention Techniques for Children Obesity
The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses
Effects of Probiotic on Modulation of the Intestinal Microbiota in Constipated Patients
Fecal Microbiota Transplantation for Chronic Functional Constipation
Fecal Microbiota Transplantation for Ulcerative Colitis
Fecal Microbiota Transplantation (FMT) for Severe Acute Pancreatitis(SAP)
Does the Fecal Microbiome Influence Rotarix Immunogenicity
Multi-Antibiotic Resistance Carriage in Gut Flora